Compare Stocks: MASI, SONVY, GNGBY, and CNMD

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CNMD CONMED	$48.87 -1.2%	$47.48	$31.44 ▼ $53.66	$1.46B	0.94	505,325 shs	56,889 shs
GNGBY Getinge	$26.87 +1.3%	$25.17	$18.99 ▼ $26.88	$7.32B	0.95	2,949 shs	200 shs
MASI Masimo	$179.95	$179.28	$125.94 ▼ $179.99	$9.42B	1.11	964,099 shs	N/A
SONVY Sonova	$68.88 +1.1%	$60.10	$42.26 ▼ $68.88	$20.53B	1.33	29,610 shs	2,753 shs

Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CNMD CONMED	+4.82%	+4.68%	+6.50%	+15.48%	+1.15%
GNGBY Getinge	0.00%	+2.02%	+6.46%	+12.28%	+11.90%
MASI Masimo	0.00%	0.00%	0.00%	0.00%	+22.22%
SONVY Sonova	+1.92%	+2.74%	+16.49%	+32.30%	+17.93%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CNMD CONMED	$48.87 -1.2%	$47.48	$31.44 ▼ $53.66	$1.46B	0.94	505,325 shs	56,889 shs
GNGBY Getinge	$26.87 +1.3%	$25.17	$18.99 ▼ $26.88	$7.32B	0.95	2,949 shs	200 shs
MASI Masimo	$179.95	$179.28	$125.94 ▼ $179.99	$9.42B	1.11	964,099 shs	N/A
SONVY Sonova	$68.88 +1.1%	$60.10	$42.26 ▼ $68.88	$20.53B	1.33	29,610 shs	2,753 shs

Don't Wait for the OpenAI IPO

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CNMD CONMED	+4.82%	+4.68%	+6.50%	+15.48%	+1.15%
GNGBY Getinge	0.00%	+2.02%	+6.46%	+12.28%	+11.90%
MASI Masimo	0.00%	0.00%	0.00%	0.00%	+22.22%
SONVY Sonova	+1.92%	+2.74%	+16.49%	+32.30%	+17.93%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CNMD CONMED	1.88	Reduce	$41.40	-15.29% Downside
GNGBY Getinge	2.00	Hold	N/A	N/A
MASI Masimo	2.00	Hold	$180.40	0.25% Upside
SONVY Sonova	2.57	Moderate Buy	N/A	N/A

Current Analyst Ratings Breakdown

Latest MASI, SONVY, GNGBY, and CNMD Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
10/21/2026	CNMD CONMED	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Sell (D+) ➝ Hold (C-)
10/8/2026	SONVY Sonova	The Goldman Sachs Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Hold ➝ Buy
10/6/2026	CNMD CONMED	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Hold (C-) ➝ Sell (D+)
9/24/2026	GNGBY Getinge	Pareto Securities Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Strong-Buy ➝ Hold
9/17/2026	CNMD CONMED	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Sell (D+) ➝ Hold (C-)
9/17/2026	GNGBY Getinge	Zacks Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Strong-Buy ➝ Hold
9/2/2026	GNGBY Getinge	UBS Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Initiated Coverage	Hold
8/31/2026	GNGBY Getinge	Nordea Equity Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Buy ➝ Hold
8/11/2026	CNMD CONMED	Zacks Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Strong Sell ➝ Hold
8/5/2026	CNMD CONMED	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Sell (D) ➝ Sell (D+)
7/30/2026	CNMD CONMED	Piper Sandler Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Neutral	$39.00 ➝ $45.00

(Data available from 10/23/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CNMD CONMED	$1.37B	1.06	$7.47 per share	6.54	$33.36 per share	1.46
GNGBY Getinge	$3.57B	2.05	$2.02 per share	13.27	$11.07 per share	2.43
MASI Masimo	$1.56B	6.05	$4.65 per share	38.74	$13.43 per share	13.40
SONVY Sonova	$4.50B	4.57	$3.90 per share	17.67	$11.03 per share	6.24

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CNMD CONMED	$47.06M	$1.85	26.37	10.33	2.15	4.12%	14.31%	6.33%	10/28/2026 (Confirmed)
GNGBY Getinge	$230.87M	$1.05	25.59	18.28	N/A	8.20%	11.55%	6.15%	N/A
MASI Masimo	-$151.50M	-$10.54	N/A	28.29	1.82	4.90%	31.33%	13.93%	N/A
SONVY Sonova	$536.96M	N/A	N/A	22.29	2.66	N/A	N/A	N/A	11/12/2026 (Estimated)

Latest MASI, SONVY, GNGBY, and CNMD Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/12/2026	N/A	SONVY Sonova	$1.10	N/A	N/A	N/A	$2.19 billion	N/A
10/28/2026	Q3 2026	CNMD CONMED	$1.00	N/A	N/A	N/A	$336.28 million	N/A
10/21/2026	Q3 2026	GNGBY Getinge	N/A	$0.32	N/A	$0.27	N/A	$875.58 million
7/29/2026	Q2 2026	CNMD CONMED	$1.11	$1.38	+$0.27	$0.77	$337.60 million	$343.49 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
CNMD CONMED	N/A	N/A	-5.59%	N/A	N/A
GNGBY Getinge	$0.29	1.08%	N/A	27.62%	N/A
MASI Masimo	N/A	N/A	N/A	N/A	N/A
SONVY Sonova	$0.68	0.99%	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CNMD CONMED	0.63	1.48	0.69
GNGBY Getinge	0.26	1.31	0.74
MASI Masimo	0.56	2.68	1.45
SONVY Sonova	0.51	1.75	1.43

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CNMD CONMED	N/A
GNGBY Getinge	N/A
MASI Masimo	85.96%
SONVY Sonova	0.01%

Insider Ownership

Company	Insider Ownership
CNMD CONMED	0.28%
GNGBY Getinge	N/A
MASI Masimo	9.70%
SONVY Sonova	0.01%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CNMD CONMED	3,900	29.95 million	29.87 million	Optionable
GNGBY Getinge	11,670	272.37 million	N/A	Not Optionable
MASI Masimo	2,200	52.37 million	47.29 million	Optionable
SONVY Sonova	18,447	298.04 million	298.01 million	Not Optionable

MASI, SONVY, GNGBY, and CNMD Headlines

Recent News About These Companies

Sonova Holding AG ADR (SONVY)

October 23 at 1:33 AM | investing.com

Consensus price target for Sonova Holding AG - depositary receipt raised 14.94% to $59.97

October 23 at 1:33 AM | msn.com

Sonova Holding (OTCMKTS:SONVY) Stock Short Interest Falls 36.0%

October 17, 2026 | americanbankingnews.com

Sonova pushes AI hearing technology beyond aids with new Roger and Integro systems

October 14, 2026 | tipranks.com

Sonova (OTCMKTS:SONVY) Hits New 52-Week High - Still a Buy?

October 12, 2026 | americanbankingnews.com

SOON Share News Today

October 10, 2026 | uk.investing.com

Sonova Holding AG (SOON) was upgraded to a Buy Rating at Goldman Sachs

October 9, 2026 | theglobeandmail.com

Goldman Sachs Upgrades Sonova Holding AG (SOON:SW) (SONVY) to Buy

October 8, 2026 | streetinsider.com

TFX or SONVY: Which Is the Better Value Stock Right Now?

October 6, 2026 | zacks.com

Sonova named Switzerland’s most innovative large company for hearing technology

September 29, 2026 | tipranks.com

Sonova Holding AG (SOON) Gets a Sell from Barclays

September 25, 2026 | theglobeandmail.com

Day by day upgrades Sonova Holding AG - Depositary Receipt to hold from sell

September 24, 2026 | msn.com

Sonova unveils new AI-powered hearing-aid platform to support growth targets

August 24, 2026 | reuters.com

IART vs. SONVY: Which Stock Is the Better Value Option?

July 22, 2026 | zacks.com

IART or SONVY: Which Is the Better Value Stock Right Now?

July 6, 2026 | zacks.com

IART vs. SONVY: Which Stock Is the Better Value Option?

June 19, 2026 | zacks.com

Sonova Earnings Call Highlights Growth, Margins And Risks

June 16, 2026 | tipranks.com

Sonova investors back record dividend and board slate at 41st AGM

June 16, 2026 | tipranks.com

GMED vs. SONVY: Which Stock Is the Better Value Option?

May 20, 2026 | zacks.com

Sonova Holding AG (SONVY) Q4 2026 Earnings Call Transcript

May 18, 2026 | seekingalpha.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

MASI, SONVY, GNGBY, and CNMD Company Descriptions

CONMED NYSE:CNMD

$48.87 -0.57 (-1.15%)

As of 12:59 PM Eastern

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

Getinge OTCMKTS:GNGBY

$26.87 +0.35 (+1.30%)

As of 11:01 AM Eastern

Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, mechanical circulatory support, advanced patient monitoring, ICU infrastructure equipment, patient flow management, and drainage solutions. The company also provides surgical perfusion, endoscopic vessel harvesting, intra-aortic balloon counterpulsation, and drainage solutions; and operating room infrastructure equipment, anesthesia, advanced patient monitoring, operating room management, and operating room integration solutions. In addition, it offers pre-cleaning, cleaning and disinfection, sterilization, consumables, endoscope reprocessing, and sterile supply management solutions; connected medical devices; bioreactor systems, DPTE systems, Getinge isolators, terminal sterilization products, and sterilizers; and vivarium, biohazardous materials handling solutions, labware cleaning and sterilization, upstream bioprocessing, and bioreactor preparation solutions. It offers its products through a network of sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia and Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.

Masimo NASDAQ:MASI

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Patient SafetyNet Surveillance, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow ventilation, neuromodulation therapeutics, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.

Sonova OTCMKTS:SONVY

$68.88 +0.73 (+1.07%)

As of 12:14 PM Eastern

Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands. The Cochlear Implants segment is involved in the design, development, manufacture, distribution, and service of hearing implants and related products under the Advanced Bionics brand. The company sells its products through independent distributors; and provides hearing care services through a network of stores and clinics. The company was formerly known as Phonak Holding AG and changed its name to Sonova Holding AG in August 2007. Sonova Holding AG was founded in 1947 and is headquartered in Stäfa, Switzerland.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest MASI, SONVY, GNGBY, and CNMD Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest MASI, SONVY, GNGBY, and CNMD Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

MASI, SONVY, GNGBY, and CNMD Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

MASI, SONVY, GNGBY, and CNMD Company Descriptions

CONMED NYSE:CNMD

Getinge OTCMKTS:GNGBY

Masimo NASDAQ:MASI

Sonova OTCMKTS:SONVY

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest MASI, SONVY, GNGBY, and CNMD Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest MASI, SONVY, GNGBY, and CNMD Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

MASI, SONVY, GNGBY, and CNMD Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

MASI, SONVY, GNGBY, and CNMD Company Descriptions

CONMED NYSE:CNMD

Getinge OTCMKTS:GNGBY

Masimo NASDAQ:MASI

Sonova OTCMKTS:SONVY

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools